Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Decrease in Short Interest

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 762,900 shares, a decrease of 50.3% from the January 31st total of 1,536,000 shares. Based on an average trading volume of 1,764,000 shares, the short-interest ratio is presently 0.4 days.

Bayer Aktiengesellschaft Price Performance

BAYRY traded down $0.01 during trading on Friday, reaching $5.93. The stock had a trading volume of 1,101,858 shares, compared to its average volume of 1,032,248. The stock has a 50 day moving average of $5.40 and a two-hundred day moving average of $6.31. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The firm has a market capitalization of $23.30 billion, a price-to-earnings ratio of -22.81 and a beta of 1.04. Bayer Aktiengesellschaft has a 1-year low of $4.79 and a 1-year high of $8.58.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.